Cymabay Therapeu (CBAY) Ownership

32.48 ↑0.00 (0.00%)
As of March 21, 2024, 3:59pm EST.

Institutional Ownership

venBio Select Advisor LLC is the biggest individual institutional holder of Cymabay Therapeu (CBAY), owning a total of 11.1 million shares. Combined, the top 48 institutional holders of CBAY own 115.52% of the company with a total of 125.7 million shares.

In the latest ownership report on December 31st 2023, the top 48 institutional holders increased their combined ownership of CBAY by 8.5 million shares. 11 institutions bought 13,030,482 total additional shares and increased their ownership by an average of 29.09%. However 6 institutions sold 4,509,917 total shares and decreased their ownership by an average of 18.48%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Cymabay Therapeu increased by a net total of 8,520,565 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
venBio Select Advisor LLC9.680%7.875%11,111,111811,1112023-12-31
BlackRock Inc8.372%23.335%9,610,2391,818,2432023-12-31
RA Capital Management, LLC6.046%0.000%6,940,00002023-12-31
Vanguard Group Inc5.494%9.718%6,306,149558,5622023-12-31
HHG PLC5.318%-10.284%6,103,797-699,6872023-12-31
T. Rowe Price Associates, Inc.3.890%134.552%4,465,1612,561,4602023-12-31
Perceptive Advisors LLC3.506%-0.465%4,024,400-18,7912023-12-31
Jennison Associates LLC3.478%12.304%3,992,711437,4372023-12-31
Franklin Resources Inc2.847%-1.209%3,267,927-39,9882023-12-31
FMR Inc2.668%95.162%3,061,9961,493,0482023-12-31
State Street Corporation2.438%22.397%2,797,916511,9722023-12-31
Adage Capital Partners Gp LLC2.290%-36.291%2,628,000-1,497,0002023-12-31
Geode Capital Management, LLC2.074%14.673%2,380,105304,5492023-12-31
Fred Alger Management, LLC1.714%-9.412%1,967,858-204,4512023-12-31
Cormorant Asset Management, LLC1.568%-53.247%1,800,000-2,050,0002023-12-31
Vestal Point Capital LP1.416%0.000%1,625,0001,625,0002023-12-31
First Turn Management LLC1.305%0.000%1,497,3311,497,3312023-12-31
Sofinnova Ventures1.230%0.000%1,411,7691,411,7692023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
venBio Select Advisor LLC9.680%7.875%11,111,111811,1112023-12-31
BlackRock Inc8.372%23.335%9,610,2391,818,2432023-12-31
RA Capital Management, LLC6.046%0.000%6,940,00002023-12-31
Vanguard Group Inc5.494%9.718%6,306,149558,5622023-12-31
HHG PLC5.318%-10.284%6,103,797-699,6872023-12-31
T. Rowe Price Associates, Inc.3.890%134.552%4,465,1612,561,4602023-12-31
Perceptive Advisors LLC3.506%-0.465%4,024,400-18,7912023-12-31
Jennison Associates LLC3.478%12.304%3,992,711437,4372023-12-31
Franklin Resources Inc2.847%-1.209%3,267,927-39,9882023-12-31
Holocene Advisors, LP2.716%0.000%3,117,6853,117,6852023-09-30
Octagon Capital Advisors LP2.678%-32.754%3,073,750-1,497,1682023-09-30
FMR Inc2.668%95.162%3,061,9961,493,0482023-12-31
TCG Crossover Management, LLC3.106%-48.382%3,048,257-2,857,1432023-03-31
State Street Corporation2.438%22.397%2,797,916511,9722023-12-31
Adage Capital Partners Gp LLC2.290%-36.291%2,628,000-1,497,0002023-12-31
Bain Capital Life Sciences Investors, LLC2.547%0.000%2,500,00002023-06-30
Point72 Asset Management, L.P.2.117%0.000%2,429,9242,429,9242023-09-30
Geode Capital Management, LLC2.074%14.673%2,380,105304,5492023-12-31
Baker Bros Advisors LP2.230%0.000%2,170,46402022-12-31
COMMODORE CAPITAL LP2.063%0.000%2,025,00002023-06-30
Novo A/S2.038%0.000%2,000,0002,000,0002023-06-30
Fred Alger Management, LLC1.714%-9.412%1,967,858-204,4512023-12-31
LAURION CAPITAL MANAGEMENT LP1.958%18.949%1,922,103306,2032023-03-31
Wagonhound Investments, LP1.603%164.011%1,840,0141,143,0672023-09-30
Cormorant Asset Management, LLC1.568%-53.247%1,800,000-2,050,0002023-12-31
Nantahala Capital Management, LLC1.824%-20.460%1,790,103-460,4562023-03-31
Foresite Capital Management IV, LLC1.576%0.000%1,787,09402023-09-30
Balyasny Asset Management LLC1.747%-12.378%1,714,818-242,2502023-06-30
Dafna Capital Management LLC1.799%-4.718%1,703,235-84,3342022-09-30
Foresite Capital Management III, LLC1.688%0.000%1,641,80402022-09-30
Vestal Point Capital LP1.416%0.000%1,625,0001,625,0002023-12-31
Great Point Partners LLC1.590%93.886%1,550,000750,5612022-12-31
First Turn Management LLC1.305%0.000%1,497,3311,497,3312023-12-31
Millennium Management LLC1.471%-51.035%1,443,994-1,505,0622023-06-30
Two Sigma Investments LLC1.446%264.829%1,419,5401,030,4432023-03-31
Sofinnova Ventures1.230%0.000%1,411,7691,411,7692023-12-31
Citadel Advisors Llc1.396%0.678%1,360,8159,1582022-12-31
Hudson Bay Capital Management LP1.373%-11.661%1,325,000-174,9002022-09-30
Logos Global Management LP1.284%0.000%1,250,0001,250,0002022-12-31
683 Capital Management LLC1.233%-18.367%1,200,000-270,0002022-12-31
Saturn V Capital Management LLC1.210%-27.105%1,187,801-441,6632023-06-30
Susquehanna International Group, LLP1.207%194.876%1,184,423782,7552023-03-31
Dimensional Fund Advisors, Inc.1.189%-1.337%1,167,413-15,8232023-06-30
Two Sigma Advisers, LLC1.178%-18.264%1,156,438-258,4002023-06-30
Affinity Asset Advisors, LLC1.173%-11.389%1,143,531-146,9802022-12-31
Altium Capital Management, LP1.053%-41.429%1,025,000-725,0002022-12-31
Longwood Capital Partners LLC1.043%0.000%1,015,0001,015,0002022-12-31
Sio Capital Management, LLC0.656%-1.197%555,610-6,7292022-06-30

Mutual Fund Ownership

Vanguard Total Stock Mkt Idx Inv is the biggest individual fund holder of Cymabay Therapeu (CBAY), owning a total of 3.5 million shares. Combined, the top 58 mutual fund holders of CBAY own 45.27% of the company with a total of 50.1 million shares.

In the latest ownership report on February 29th 2024, the top 58 fund holders increased their combined ownership of CBAY by 888 thousand shares. 3 funds bought 1,018,245 total additional shares and increased their ownership by an average of 0.87%. However 6 funds sold 130,304 total shares and decreased their ownership by an average of 1.7%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Cymabay Therapeu increased by a net total of 887,941 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv3.070%-0.298%3,523,557-10,5172024-02-29
iShares Russell 2000 ETF2.386%-0.016%2,738,180-4472024-02-29
Vanguard Institutional Extnd Mkt Idx Tr1.389%-1.052%1,594,737-16,9562024-02-29
Janus Henderson Glb Life Scn I2 USD0.969%-7.925%1,112,074-95,7162024-02-29
Fidelity Canadian Large Cp Mlt Ast Bs O0.871%0.000%1,000,0001,000,0002024-02-29
iShares Russell 2000 Growth ETF0.866%0.236%994,3082,3452024-02-29
iShares Biotechnology ETF0.721%-0.448%827,419-3,7252024-02-29
State St Russell Sm/Mid Cp® Indx NL Cl C0.598%2.372%686,19915,9002024-02-29
Franklin Small Cap Growth Adv0.577%0.000%662,70002024-02-29
Fidelity Extended Market Index0.529%-0.482%607,311-2,9432024-02-29

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv3.070%-0.298%3,523,557-10,5172024-02-29
Vanguard Instl Ttl Stck Mkt Idx Tr3.043%24.541%2,986,738588,5372023-03-31
iShares Russell 2000 ETF2.386%-0.016%2,738,180-4472024-02-29
T. Rowe Price New Horizons1.756%178.949%2,015,1141,292,7182023-12-31
US Small-Cap Growth II Equity Comp1.756%178.949%2,015,1141,292,7182023-12-31
Janus Henderson Global Life Sciences1.406%-3.630%1,613,473-60,7802023-12-31
Janus Henderson Global Life Sciences D1.406%-3.630%1,613,473-60,7802023-12-31
Vanguard Institutional Extnd Mkt Idx Tr1.389%-1.052%1,594,737-16,9562024-02-29
Franklin Biotechnology Discv A(acc)USD1.354%-8.522%1,554,293-144,8002024-01-31
Alger Small Cap Focus Composite1.172%-9.104%1,344,970-134,7162024-01-31
Alger Small Cap Focus I1.172%-9.104%1,344,970-134,7162024-01-31
Vanguard Extended Market Index Investor1.278%-0.019%1,254,658-2432023-08-31
Jennison Health Sciences Equity1.064%-18.136%1,220,748-270,4472023-12-31
PGIM Jennison Health Sciences Z1.064%0.000%1,220,74802024-01-31
Janus Selection Global Life Science AUSD1.061%-5.536%1,217,523-71,3492023-12-31
MEDICAL BioHealth EUR Acc1.019%0.000%1,169,28602023-11-30
Fidelity Small Cap Index0.998%1.726%1,145,79019,4432024-01-31
Janus Henderson Glb Life Scn I2 USD0.969%-7.925%1,112,074-95,7162024-02-29
Lord Abbett Developing Growth A0.875%137.919%1,004,885582,5202024-01-31
Fidelity Canadian Large Cp Mlt Ast Bs O0.871%0.000%1,000,0001,000,0002024-02-29
iShares Russell 2000 Growth ETF0.866%0.236%994,3082,3452024-02-29
Janus Henderson Triton D0.846%-18.695%970,743-223,2152023-12-31
Janus Henderson US SMID Cap Growth0.846%-18.695%970,743-223,2152023-12-31
Fidelity® Small Cap Index0.833%2.791%945,09025,6572023-10-31
iShares Biotechnology ETF0.721%-0.448%827,419-3,7252024-02-29
Fidelity® Small Cap Growth0.700%621.318%794,236684,1272023-10-31
Invesco Dynamic Biotech & Genome ETF0.801%0.000%785,83202023-07-31
Franklin Biotechnology Discovery A0.684%0.000%775,55302023-11-30
Fidelity Small Cap Growth0.667%-6.704%765,712-55,0242024-01-31
PGIM Jennison Small Company A0.670%0.000%759,68102023-11-30
State St Russell Sm/Mid Cp® Indx NL Cl C0.598%2.372%686,19915,9002024-02-29
Franklin Small Cap Growth Adv0.577%0.000%662,70002024-02-29
Franklin US Small Cap Growth Equity0.577%0.000%662,70002023-12-31
Fidelity Extended Market Index0.529%-0.482%607,311-2,9432024-02-29
HBM Healthcare Investments AG Ord0.523%42.420%600,000178,7102023-12-31
FIAM Small Cap Core CIT Cl B0.517%15.843%593,00081,1002024-01-31
Invesco DWA SmallCap Momentum ETF0.509%0.000%496,03202023-06-30
Fidelity® Extended Market Index0.472%3.612%459,76016,0262023-05-31
Invesco DWA Healthcare Momentum ETF0.452%0.000%440,25402023-06-22
DFA US Small Cap I0.383%0.000%373,64502023-04-30
DFA US Micro Cap I0.330%0.000%320,92702023-03-31
APO Medical Opportunities R0.303%0.000%294,29802023-02-28
EAM Ultra Micro Cap0.286%-17.779%278,546-60,2332023-01-31
Janus Henderson Horizon Bio E2 USD Acc0.271%6.837%263,54116,8642023-02-28
Janus Henderson Hrzn Biotec E2 USD0.271%6.837%263,54116,8642023-02-28
iShares Micro-Cap ETF0.217%0.000%211,13502023-03-31
BlackRock Extended Mkt Composite0.208%11.015%202,37320,0802023-03-31
EAM Micro Cap0.191%0.000%185,430185,4302023-01-31
SPDR® S&P Pharmaceuticals ETF0.183%0.000%177,76302023-03-31
BlackRock Extended Equity Market K0.180%9.735%175,32415,5532023-03-31
Fidelity® Total Market Index0.146%0.000%140,86802023-01-31
Xtrackers S&P 500 2x LvrgdDailySwapETF1C0.134%0.000%127,19602023-01-31
RIM Global Bioscience EUR0.130%0.000%122,56602022-10-31
Dimensional US Small Cap ETF0.128%0.000%121,53202023-01-31
Invesco Raymond James SB-1 Equity ETF0.110%0.000%103,64602023-01-31
T. Rowe Price Total Equity Market Idx0.116%37.693%97,90026,8002022-09-30
Fidelity® Series Total Market Index0.101%3.215%95,7972,9842022-12-31
Pleiades Small Cap Equity A0.091%0.000%85,94902022-12-31

Discussions

Please log in or register to share your thoughts.

micmic

$CBAY we need to get moving

0 Like Report
a

$CBAY beauty. Bag secured

0 Like Report
iburnmoney

$CBAY Guys when can we expect that 30% drop?

0 Like Report